Boeing to pay $200 million to settle U.S. charges it misled investors about 737 MAX

Boeing to pay $200 million to settle U.S. charges it misled investors about 737 MAX

Boeing to pay $200 million to settle U.S. charges it misled investors about 737 MAX By Reuters

Breaking News

‘;

Stock Markets 38 minutes ago (Sep 22, 2022 05:42PM ET)

(C) Reuters. Grounded Boeing 737 MAX aircraft are seen parked at Grant County International Airport in Moses Lake, Washington, U.S. November 17, 2020. REUTERS/Lindsey Wasson

By David Shepardson

WASHINGTON (Reuters) – Boeing (NYSE:BA) Co will pay $200 million to settle civil charges from the U.S. Securities and Exchange Commission that it misled investors about its 737 MAX, which was grounded for 20 months after two fatal crashes killed 346 people, the agency said Thursday.

The SEC also said former Boeing Chief Executive Dennis Muilenburg had agreed to pay $1 million.

“In times of crisis and tragedy, it is especially important that public companies and executives provide full, fair, and truthful disclosures to the markets,” SEC Chair Gary Gensler said in a statement. He added that Boeing and Muilenburg “failed in this most basic obligation.”

The SEC said Boeing and Muilenburg did not admit or deny the SEC’s findings. The regulatory agency said a fund will be established for the benefit of harmed investors.

The SEC charged Boeing and Muilenburg “with making materially misleading public statements following crashes of Boeing airplanes in 2018 and 2019.”

Boeing confirmed the settlement and noted it did not admit or deny wrongdoing. It said it had made “fundamental changes that have strengthened our safety processes” and said the “settlement is part of the company’s broader effort to responsibly resolve outstanding legal matters related to the 737 MAX accidents.”

The crashes were linked to a flight control system called the Maneuvering Characteristics Augmentation System (MCAS). The SEC said “after the first crash, Boeing and Muilenburg knew that MCAS posed an ongoing airplane safety issue, but nevertheless assured the public that the 737 MAX airplane was ‘as safe as any that has ever flown the skies.'”

After the second crash, the SEC said, “Boeing and Muilenburg assured the public that there were no slips or gaps in the certification process with respect to MCAS, despite being aware of contrary information.”

In January 2021, Boeing agreed to pay $2.5 billion in fines and compensation to resolve a U.S. Justice Department criminal investigation into the 737 MAX crashes.

The Justice Department settlement, which allowed Boeing to avoid prosecution, included a fine of $243.6 million, compensation to airlines of $1.77 billion and a $500 million crash-victim fund over fraud conspiracy charges related to the plane’s flawed design.

In December 2019, Boeing fired Muilenburg after the company clashed with regulators over the timing of the 737 MAX’s return to service.

“Boeing and Muilenburg put profits over people by misleading investors about the safety of the 737 MAX all in an effort to rehabilitate Boeing’s image following two tragic accidents that resulted in the loss of 346 lives and incalculable grief to so many families,” said Gurbir Grewal, director of the SEC’s Enforcement Division.

Boeing to pay $200 million to settle U.S. charges it misled investors about 737 MAX

U.S. cutting global donations of Pfizer COVID shots as demand slowsBy Reuters – Sep 22, 2022

By Michael Erman NEW YORK (Reuters) – The United States is significantly cutting back the number of Pfizer/BioNTech COVID-19 vaccine doses it will buy for donation to poorer…

Chipmaker Qualcomm says automotive future business expands to $30 billionBy Reuters – Sep 22, 2022

By Jane Lanhee Lee and Akash Sriram (Reuters) -U.S. chip designer Qualcomm (NASDAQ:QCOM) Inc on Thursday said its automotive business “pipeline” increased to $30 billion, up more…

After-Hours Movers: Spectrum Pharm Sinks on Negative FDA Panel, Costco Dips on EPSBy Investing.com – Sep 22, 2022

After-Hours Stock Movers:
Spectrum Pharmaceuticals (NASDAQ:SPPI) 28% LOWER; The FDA’s Oncologic Drugs Advisory Committee (ODAC) met to review poziotinib for the treatment of…

Our Apps



Terms And Conditions
Privacy Policy
Risk Warning

(C) 2007-2022 Fusion Media Limited. All Rights Reserved.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.